Quoin Pharmaceuticals (QNRX) Operating Expenses (2021 - 2026)
Quoin Pharmaceuticals (QNRX) posted Operating Expenses of $5.1 million for Q1 2026, up 13.51% sequentially from $4.5 million in Q4 2025, and up 29.67% YoY from $4.0 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Operating Expenses (2021 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Operating Expenses for 6 years, with the latest figure at $5.1 million in Q1 2026.
- Quarterly Operating Expenses rose 29.67% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (up 58.38% YoY) and the FY2025 annual result came in at $16.3 million, up 70.97% from the prior year.
- Operating Expenses improved to $5.1 million in Q1 2026 per QNRX's latest filing, from $4.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $5.1 million in Q1 2026 and troughed at $2.1 million in Q4 2022.
- A 5-year average of $2.9 million and a median of $2.5 million in 2024 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 173.13% in 2022, down 30.04% in 2022.
- Over 5 years, Operating Expenses stood at $2.1 million in 2022, then rose by 6.32% to $2.2 million in 2023, then increased by 8.45% to $2.4 million in 2024, then soared by 87.96% to $4.5 million in 2025, then climbed by 13.51% to $5.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $5.1 million, $4.5 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | 5.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.13 Mn |
| Dec 31, 2025 | 4.52 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 3.79 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | 2.26 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 2.33 Mn |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Jun 30, 2021 | 976,890.00 |